# Surmodics completes $43/share merger with BCE Parent, goes private

Surmodics completed its merger with BCE Parent, LLC on November 19, 2025, with shareholders receiving $43.00 per share in cash. The company will delist from Nasdaq and become a private subsidiary.

- Type: Acquisition
- Announced: 2025-11-19
- Where: United States
- Status: completed
- Products: medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Surmodics](https://endata.com/companies/30343.md) (target)
- [BCE Parent](https://endata.com/companies/88561.md) (acquirer)

## Sources

- [stocktitan.net](https://www.stocktitan.net/sec-filings/SRDX/8-k-surmodics-inc-reports-material-event-8da1650ff4fe.html), 2025-11-19: "Surmodics, Inc. (SRDX) completed its previously announced merger with BCE Parent, LLC on November 19, 2025, with Surmodics becoming a wholly owned subsidiary of Parent."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.